According to a study of data from the National Oncologic PET Registry (NOPR) published online in the Journal of Clinical Oncology (JCO) on March 24th, clinicians changed the intended care of more than one in three cancer patients as the results of FDG-PET scan findings. There were over 1500 participating facilities that contributed FDG-PET scan data from the nearly 23,000 patients involved in the study. Analysis of registry data reported in the JCO article found that FDG-PET is associated with a 36.5% change in the treatment or no-treatment decision.
